Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 10 Dec 2013 |
| New stock buyback program & financial impact of The BioAg Alliance | 10 Dec 2013 |
| Details on financial support to M&G Chemicals | 27 Nov 2013 |
| Financial calendar 2014 | 25 Nov 2013 |
| Major shareholder announcement | 20 Nov 2013 |